DOP2002000519A - PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BICYCLE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH - Google Patents

PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BICYCLE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH

Info

Publication number
DOP2002000519A
DOP2002000519A DO2002000519A DO2002000519A DOP2002000519A DO P2002000519 A DOP2002000519 A DO P2002000519A DO 2002000519 A DO2002000519 A DO 2002000519A DO 2002000519 A DO2002000519 A DO 2002000519A DO P2002000519 A DOP2002000519 A DO P2002000519A
Authority
DO
Dominican Republic
Prior art keywords
treatment
procedure
preparation
cellular growth
abnormal cellular
Prior art date
Application number
DO2002000519A
Other languages
Spanish (es)
Inventor
David Harold Brown Ripin
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of DOP2002000519A publication Critical patent/DOP2002000519A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/027—Organoboranes and organoborohydrides

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere a procedimientos para preparar compuestos de formula. Y a sales, pro fármacos y solvatos farmacéuticamente aceptables de los mismos, en la que R1, R3, R4, R5, R11, m y p son como se han definido en este documento. Los compuestos de formula 1 son útiles en el tratamiento del crecimiento celular anormal en mamíferos por la administración de composiciones farmacéuticas.The invention relates to processes for preparing compounds of formula. And pharmaceutically acceptable salts, pro drugs and solvates thereof, wherein R1, R3, R4, R5, R11, m and p are as defined herein. The compounds of formula 1 are useful in the treatment of abnormal cell growth in mammals by the administration of pharmaceutical compositions.

DO2002000519A 2001-11-30 2002-11-21 PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BICYCLE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH DOP2002000519A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33464701P 2001-11-30 2001-11-30

Publications (1)

Publication Number Publication Date
DOP2002000519A true DOP2002000519A (en) 2003-05-31

Family

ID=23308141

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2002000519A DOP2002000519A (en) 2001-11-30 2002-11-21 PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BICYCLE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH

Country Status (29)

Country Link
US (1) US20030144506A1 (en)
EP (1) EP1448551B1 (en)
JP (1) JP4220388B2 (en)
KR (1) KR20040054813A (en)
CN (1) CN1639149A (en)
AR (1) AR037591A1 (en)
AT (1) ATE377009T1 (en)
AU (1) AU2002337428A1 (en)
BR (1) BR0214606A (en)
CA (1) CA2462149C (en)
DE (1) DE60223279T2 (en)
DO (1) DOP2002000519A (en)
ES (1) ES2295409T3 (en)
GT (1) GT200200245A (en)
HN (1) HN2002000334A (en)
HU (1) HUP0500117A3 (en)
IL (1) IL160971A0 (en)
MX (1) MXPA04005157A (en)
PA (1) PA8558601A1 (en)
PE (1) PE20030643A1 (en)
PL (1) PL370911A1 (en)
PY (1) PY0229003A (en)
RS (1) RS44004A (en)
RU (1) RU2004116345A (en)
SV (1) SV2004001419A (en)
TN (1) TNSN02096A1 (en)
TW (1) TW200300691A (en)
WO (1) WO2003045939A1 (en)
ZA (1) ZA200402054B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2005119172A (en) * 2002-12-18 2006-01-20 Пфайзер Продактс Инк. (Us) 4-ANILINKHINAZOLINE DERIVATIVES FOR TREATMENT OF PATHOLOGICAL CELL GROWTH
BR0317259A (en) * 2002-12-19 2005-11-08 Pfizer Prod Inc E-2-Methoxy-n- (3- {4- [3-methyl-4- (6-methylpyridin-3-yloxy) -phenylamino] -quinazolin-6-yl} -allyl) -acetamide complexes production and use methods
RU2005125607A (en) * 2003-04-09 2006-03-27 Пфайзер Продактс Инк. (Us) METHODS FOR PRODUCING N (PYRIDINYLOXY) -PHENYLAMINO) CHINAZOLINYL) ALLYL) ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS, ALSO INTERMEDIATE COMPOUNDS FOR SUCH METHODS AND METHODS
WO2006074147A2 (en) 2005-01-03 2006-07-13 Myriad Genetics, Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
AU2004253967B2 (en) * 2003-07-03 2010-02-18 Cytovia, Inc. 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
US20050192298A1 (en) * 2004-02-27 2005-09-01 Pfizer Inc Crystal forms of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide
KR20080095915A (en) * 2004-05-06 2008-10-29 워너-램버트 캄파니 엘엘씨 4-phenylamino-quinazolin-6-yl-amide
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CN101336162A (en) * 2005-12-02 2008-12-31 纸品制造有限公司 Holographic hose laminate for packaging and method of making the same
JP2022502495A (en) 2018-09-25 2022-01-11 ブラック ダイアモンド セラピューティクス，インコーポレイティド Quinazoline derivatives as tyrosine kinase inhibitors, compositions, methods of their preparation, and their use
AU2020328598A1 (en) 2019-08-15 2022-03-03 Black Diamond Therapeutics, Inc. Alkynyl quinazoline compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW321649B (en) * 1994-11-12 1997-12-01 Zeneca Ltd
DE19501481A1 (en) * 1995-01-19 1996-07-25 Bayer Ag 2,8-disubstituted quinazolinones
GB9603095D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
UA71945C2 (en) * 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
EP1292591B1 (en) * 2000-06-22 2005-02-02 Pfizer Products Inc. Substituted bicyclic derivatives for the treatment of abnormal cell growth

Also Published As

Publication number Publication date
PA8558601A1 (en) 2003-06-30
JP2005515986A (en) 2005-06-02
US20030144506A1 (en) 2003-07-31
RU2004116345A (en) 2005-03-27
ZA200402054B (en) 2005-05-23
DE60223279T2 (en) 2008-05-29
EP1448551A1 (en) 2004-08-25
CA2462149A1 (en) 2003-06-05
KR20040054813A (en) 2004-06-25
CA2462149C (en) 2010-06-22
RS44004A (en) 2006-10-27
IL160971A0 (en) 2004-08-31
SV2004001419A (en) 2004-02-24
MXPA04005157A (en) 2004-08-11
BR0214606A (en) 2004-09-14
HUP0500117A3 (en) 2008-03-28
ATE377009T1 (en) 2007-11-15
PL370911A1 (en) 2005-05-30
JP4220388B2 (en) 2009-02-04
TW200300691A (en) 2003-06-16
CN1639149A (en) 2005-07-13
GT200200245A (en) 2003-09-24
EP1448551B1 (en) 2007-10-31
PY0229003A (en) 2004-06-01
DE60223279D1 (en) 2007-12-13
ES2295409T3 (en) 2008-04-16
PE20030643A1 (en) 2003-07-23
AU2002337428A1 (en) 2003-06-10
AR037591A1 (en) 2004-11-17
HUP0500117A2 (en) 2005-05-30
HN2002000334A (en) 2003-02-21
WO2003045939A1 (en) 2003-06-05
TNSN02096A1 (en) 2005-12-23

Similar Documents

Publication Publication Date Title
UY28135A1 (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH
ECSP024393A (en) SUBSTITUTED BICYCLE DERIVATIVES FOR THE TREATMENT OF NORMAL CELLULAR GROWTH
ECSP055633A (en) NEW BENZOIMIDAZOLUTILES DERIVATIVES AS ANTIPROLIFERATIVE ANGENTS
PA8487601A1 (en) USEFUL SUBSTITUTED BICYCLE DERIVATIVES AS AGENTS AGAINST CANCER
AR037517A1 (en) DERIVATIVES OF NAFTIRIDINES, A PROCESS FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF AN INFLAMMATORY DISEASE
PA8490601A1 (en) QUINOLIN-2-ONA DERIVATIVES SUBSTITUTED WITH HETEROARILO USEFUL AS ANTICANCERIGEN AGENTS.
UY27388A1 (en) NEW COMPOUNDS
DOP2009000124A (en) BENZAMIDA DERIVATIVES AS AGONISTA EP4 RECEIVERS
CO4810375A1 (en) DERIVATIVES OF 9-AMINO-3-KETO Erythromycin
UY28510A1 (en) CHEMICAL COMPOUNDS
UY29427A1 (en) SUBSTITUTED DERIVATIVES OF 2,3,4,5- TETRAHIDRO-1H-PIRIDO (4,3-B) INDOL, COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
DOP2002000519A (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BICYCLE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH
ECSP088829A (en) BENCIMIDAZOL 5-SULFONAMIDE DERIVATIVES AS CANNABINOID 1 RECEPTOR LIGANDS (CB1)
ATE386725T1 (en) HETEROCYCLYL COMPOUNDS
UY30397A1 (en) SUBSTITUTED DERIVATIVES OF THE (3AS, 7AS) -1,3A, 4,5,6,7-HEXAHIDRO-3H-BENZOIMIDAZOL-2-ONA, PREPARATION PROCESS, COMPOSITIONS CONTAINING AND APPLICATIONS
UY28536A1 (en) DERIVATIVES OF BENCIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATION AND USES OF THE SAME.
UY27685A1 (en) INDOLIL-UREA DERIVED FROM USEFUL TIENOPIRIDINS AS ANTIANGIOGEN AGENTS, AND PROCEDURES FOR USE
UY28357A1 (en) DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATION OF THE SAME AND ITS USES
MX2007003105A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i.
ECSP024377A (en) DERIVATIVES OF BENZO (G) QUINOLINA
UY27557A1 (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BICYCLE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH.
PA8474401A1 (en) 3-KETO TRICYCLIC DERIVATIVES OF 6-0-METHYLERITHROMYCIN
UY26785A1 (en) SUBSTITUTED BICYCLIC DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH
SE0400014D0 (en) Heterocyclic derivatives
CL2004000744A1 (en) METHOD FOR PREPARING DERIVATIVES OF PHENYLAMINOQUINAZOLINS; INTERMEDIARY COMPOUND; AND ITS PREPARATION METHOD.